<< Read Full Article
<< Read Full Article
Glaxo Gets Some Good News
The class of diabetes drugs that includes GlaxoSmithKline's (GSK Quote) Avandia doesn't increase the risk of death or heart-failure hospitalizations compared with other medications, a new study says.
The report, published Monday in the Journal of the American College of Cardiology, adds another element to the controversy over Avandia and drugs like it, called thiazolidinediones, or TZDs.
Last month, a study published by the New England Journal of Medicine said people who used Avandia had a 43% greater possibility of heart attacks than people taking other diabetes medications. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |
Connect with TheStreet